Guaranteeing Access to Medicines: Reforming Trade and Investment Treaties in the COVID-19 Era

Eight months into COVID-19, what is the status of the international investment regime and access to essential medicines? The GDP Center’s Working Group on Trade and Access to Medicines will host a panel discussion on trade, investment regime, and access to essential medicines. The event is co-sponsored with the South Centre, an intergovernmental organization of developing nations based in Switzerland.

Panelists:

-Carlos Correa, Executive Director, South Centre
-Mustaqeem de Gama, Counsellor, South Africa WTO Mission
-Mariangela Simao, Assistant Director-General for Drug Access, Vaccines and Pharmaceuticals, World Health Organization
-Yousuf Vawda, Professor & Senior Research Associate, University of Kwazulu-Natal School of Law
-Deborah Gleeson, Senior Lecturer, La Trobe University
-Kevin P. Gallagher, Director, Global Development Policy Center; Professor, Pardee School of Global Studies Boston University

GuaranteeingAccessMedicines: